Dhampur Bio Organics Limited has informed the Exchange regarding Appointment of Dr. Ran Vijay Singh as Vice President - New Product Development of the company w.e.f. July 12, 2025.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics has appointed Dr. Ran Vijay Singh as Vice President – New Product Development, effective July 12, 2025. He joins as a full-time employee and will focus on driving product innovation and R&D strategy. Dr. Singh brings over 30 years of senior leadership experience in the FMCG sector, with deep expertise in confectionery, bakery, chocolate, and gum innovation. The appointment was disclosed to the exchanges under SEBI Listing Regulations. No details were shared on his compensation package.
This is a routine senior management hire aimed at strengthening the company's new product development capabilities. For shareholders, it signals a focus on innovation-led growth in FMCG categories, though the stock is unlikely to react materially to a VP-level appointment.